NI200700188A - Procesos y compuestos para la preparación de derivados de naftilindol sustituidos - Google Patents

Procesos y compuestos para la preparación de derivados de naftilindol sustituidos

Info

Publication number
NI200700188A
NI200700188A NI200700188A NI200700188A NI200700188A NI 200700188 A NI200700188 A NI 200700188A NI 200700188 A NI200700188 A NI 200700188A NI 200700188 A NI200700188 A NI 200700188A NI 200700188 A NI200700188 A NI 200700188A
Authority
NI
Nicaragua
Prior art keywords
substituted
processes
preparation
derivatives
naftilindol
Prior art date
Application number
NI200700188A
Other languages
English (en)
Inventor
Vladimir A Dragan
John Richard Potoski
Wayne G Mcmahon
Jean Louise Helom
Xinxu Shi
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NI200700188A publication Critical patent/NI200700188A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención proporciona procesos para la preparación de derivados de naftilindol sustituidos de fórmula (I) que pueden usarse como inhibidores del inhibidor del activador de plasminógeno-1 (PAI-I). En ciertas realizaciones de la invención, los procesos implican reacciones que incluyen uno o más de una oxidación de Oppenauer, una síntesis de indol de Fischer, una escisión de éter metílico o acoplamiento de un metiltetrazol sustituido con un naftol sustituido.
NI200700188A 2005-01-27 2007-07-27 Procesos y compuestos para la preparación de derivados de naftilindol sustituidos NI200700188A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64761805P 2005-01-27 2005-01-27

Publications (1)

Publication Number Publication Date
NI200700188A true NI200700188A (es) 2008-05-09

Family

ID=36570379

Family Applications (1)

Application Number Title Priority Date Filing Date
NI200700188A NI200700188A (es) 2005-01-27 2007-07-27 Procesos y compuestos para la preparación de derivados de naftilindol sustituidos

Country Status (21)

Country Link
US (2) US7323483B2 (es)
EP (1) EP1856104A1 (es)
JP (1) JP2008528618A (es)
KR (1) KR20070103744A (es)
CN (1) CN101111491A (es)
AR (1) AR053437A1 (es)
AU (1) AU2006208021A1 (es)
BR (1) BRPI0606871A2 (es)
CA (1) CA2595376A1 (es)
CR (1) CR9215A (es)
GT (1) GT200600032A (es)
HN (1) HN2006003347A (es)
IL (1) IL183712A0 (es)
MX (1) MX2007008952A (es)
NI (1) NI200700188A (es)
NO (1) NO20072879L (es)
PE (1) PE20061200A1 (es)
RU (1) RU2007121255A (es)
TW (1) TW200637850A (es)
WO (1) WO2006081455A1 (es)
ZA (1) ZA200706203B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007092207A1 (en) * 2006-02-03 2007-08-16 Wyeth Compositions for the delivery of substituted naphthyl indole derivatives and methods of their use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95584A (en) 1989-09-07 1995-03-15 Abbott Lab Indole-, benzoporene- and benzothiophene compounds including lipoxygenase-inhibiting compounds and pharmaceutical compounds containing them
US5151435A (en) 1991-04-08 1992-09-29 Merck & Co., Inc. Angiotensin ii antagonists incorporating an indole or dihydroindole
IL101785A0 (en) 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL109568A0 (en) 1993-05-19 1994-08-26 Fujisawa Pharmaceutical Co Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
CA2134192A1 (en) 1993-11-12 1995-05-13 Michael L. Denney 5, 6-bicyclic glycoprotein iib/iiia antagonists
US5552412A (en) 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
NZ318228A (en) 1995-09-01 1999-07-29 Lilly Co Eli Indolyl neuropeptide y receptor antagonists
WO1998008818A1 (en) 1996-08-26 1998-03-05 Genetics Institute, Inc. Inhibitors of phospholipase enzymes
US6703527B2 (en) 2001-05-24 2004-03-09 Nikken Chemicals Co., Ltd. Method for oxidation of allyl alcohol
TWI224101B (en) 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
TW591020B (en) 2001-06-20 2004-06-11 Wyeth Corp 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)

Also Published As

Publication number Publication date
WO2006081455A1 (en) 2006-08-03
ZA200706203B (en) 2009-12-30
CA2595376A1 (en) 2006-08-03
IL183712A0 (en) 2007-09-20
NO20072879L (no) 2007-06-26
EP1856104A1 (en) 2007-11-21
JP2008528618A (ja) 2008-07-31
CN101111491A (zh) 2008-01-23
US20080071091A1 (en) 2008-03-20
PE20061200A1 (es) 2006-12-19
BRPI0606871A2 (pt) 2009-07-21
MX2007008952A (es) 2007-09-18
HN2006003347A (es) 2011-03-30
TW200637850A (en) 2006-11-01
KR20070103744A (ko) 2007-10-24
GT200600032A (es) 2006-11-14
US7323483B2 (en) 2008-01-29
AU2006208021A1 (en) 2006-08-03
CR9215A (es) 2007-11-23
RU2007121255A (ru) 2009-03-10
US20060183917A1 (en) 2006-08-17
AR053437A1 (es) 2007-05-09

Similar Documents

Publication Publication Date Title
CR11618A (es) Inhibidores macrocíclicos de serina proteasa
CL2008001017A1 (es) Compuestos derivados de indol, activadores de glucoquinasa; composicion farmaceutica que los comprende; y su uso para la prevencion o el tratamiento de diabetes u obesidad.
ECSP088222A (es) Agonistas de receptores adrenérgicos alfa2c funcionalmente selectivos
DOP2015000264A (es) Derivados de azaadamantano y métodos de uso de los mismos
BRPI0606379A2 (pt) triazolftalazinas
DOP2010000178A (es) Peptidil nitrilos como inhibidores de dipeptidil peptidasa i
MX2009009552A (es) Inhibidores de metaloproteasa que contienen una porcion heterociclica.
CR20110467A (es) Derivados de benzofuranilo como inhibidores de la glucoquinasa
CL2012003104A1 (es) Compuestos derivados de multiheteroarilos, inhibidores de prostaglandina d sintasa hematopoyetica (h-pgds); y composicion farmaceutica que los comprende.
AR069531A1 (es) Derivados de indolinona y procedimiento para su fabricacion
CL2011002433A1 (es) Compuestos tetraciclicos, inhibidores de alk; composicion farmaceutica que comprende dichos compuestos, utiles en la profilaxis o el tratamiento de cancer, metastasis de cancer, depresion o un trastorno de la funcion cognitiva.
UY32049A (es) Inhibidores de cmet
UY31806A (es) Compuestos de tiazole y oxazole de sulfonamida de benceno
ECSP10010722A (es) Compuestos orgánicos
GT200600035A (es) Aminopiridinas como inhibidores de beta-secretasa
EA200970605A1 (ru) Ингибиторы mapk/erk-киназ
ECSP099335A (es) Compuestos heterocíclicos que contienen nitrógeno y métodos de uso de los mismos
CL2007001391A1 (es) Compuestos derivados de pirrolidinas sustituidas, inhibidores del factor xa y/o inhibidores sobre la serina proteasa; composicion farmaceutica que comprende a dichos compuestos; proedimiento para preparar la composicon farmaceutica; y uso de los compuestos preparar un medicamneto con un efecto antitrombotico
EA200801145A1 (ru) Спироциклические производные хиназолина в качестве ингибиторов pde7
UY31273A1 (es) Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53
GT200600334A (es) Proceso para la sintesis de los moduladores del receptor de progesterona
CR11584A (es) Derivados de oxindol sustituidos y uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina
UY30801A1 (es) Compuestos calciliticos
NI200700188A (es) Procesos y compuestos para la preparación de derivados de naftilindol sustituidos
CR11860A (es) Derivados de dibenzotiazepina y sus usos - 424